About PURAPHARM Company

The Group is a Hong Kong Chinese medicine company leading the concentrated Chinese medicine formula granule market. It is engaged in R&D, production, marketing and sales of concentrated traditional Chinese medicine formula granule products under its “Nongben Fong” brand. The Group is one of only five overseas enterprises approved by the China Food and Drug Administration to produce and sell concentrated Chinese medicine formula granular products in China. Furthermore, the Group is a national standard laboratory certified by CNAS according to ISO17025 by the China National Accreditation Committee for Conformity Assessment, which indicates that the Group's test reports have been recognized by more than 70 countries around the world. Since 2004, the Group has been providing concentrated Chinese medicine formula granular products to Chinese medicine clinics in most hospitals and medical institutions in Hong Kong. At present, the Group has established a leading position in the Hong Kong concentrated Chinese medicine formula granule product market. It is the largest supplier, and is also a leading chain of traditional Chinese medicine clinics in Hong Kong. Since its establishment in 1998, the Group has been committed to the modernization and internationalization of traditional Chinese medicine, and has collaborated with many internationally renowned scholars and scientific research institutes to establish its position as a pioneer of science and technology in the traditional Chinese medicine market. Through continuous innovation, the Group has been hailed as a leader in the industry in terms of R&D, production, marketing and sales of traditional Chinese medicines, quality control, and even basic scientific research. The Group has set up its own traditional Chinese medicine research and production base in Nanning, Guangxi, China. The production facilities not only meet the GMP standards of the national good production practices, but also meet the Australian Medicines Administration's TGA standard, which is one of the most stringent international standard certifications, and the PIC/S pharmaceutical standards of the International Pharmaceutical Inspection Agreement. The Group is also the only manufacturer that has obtained USP certification from the US Pharmacopeia and approved for its concentrated traditional Chinese medicine formula granular products. The Group's own national standard laboratory has been certified by CNAS according to ISO17025. This is an international multilateral mutual certification system, making the Group one of the most advanced traditional Chinese medicine research and production facilities in Asia. With advanced development concepts and production technology, a series of traditional Chinese medicine health retail products developed by the Group, such as famous brands such as Ganoderma lucidum, Angusheng, Yibangsu, and Wu Fanong, are widely popular in Hong Kong and overseas markets.